Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Haskó G[au]:

CD39 and CD73 in immunity and inflammation. Antonioli L et al. Trends Mol Med. (2013)

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Pacher P et al. Nat Rev Cardiol. (2018)

PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. Mukhopadhyay P et al. J Hepatol. (2017)

Search results

Items: 1 to 50 of 195

1.

Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy.

Matyas C, Erdelyi K, Trojnar E, Zhao S, Varga ZV, Paloczi J, Mukhopadhyay P, Nemeth BT, Haskó G, Cinar R, Rodrigues RM, Ait Ahmed Y, Gao B, Pacher P.

Hepatology. 2019 Aug 30. doi: 10.1002/hep.30916. [Epub ahead of print]

PMID:
31469200
2.

The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Antonioli L, Blandizzi C, Pacher P, Haskó G.

Pharmacol Rev. 2019 Jul;71(3):345-382. doi: 10.1124/pr.117.014878. Review.

3.

VEGF-A from Granuloma Macrophages Regulates Granulomatous Inflammation by a Non-angiogenic Pathway during Mycobacterial Infection.

Harding JS, Herbath M, Chen Y, Rayasam A, Ritter A, Csoka B, Hasko G, Michael IP, Fabry Z, Nagy A, Sandor M.

Cell Rep. 2019 May 14;27(7):2119-2131.e6. doi: 10.1016/j.celrep.2019.04.072.

4.

P2X4 receptors, immunity, and sepsis.

Antonioli L, Blandizzi C, Fornai M, Pacher P, Lee HT, Haskó G.

Curr Opin Pharmacol. 2019 Aug;47:65-74. doi: 10.1016/j.coph.2019.02.011. Epub 2019 Mar 25. Review.

PMID:
30921560
5.

Rethinking Communication in the Immune System: The Quorum Sensing Concept.

Antonioli L, Blandizzi C, Pacher P, Guilliams M, Haskó G.

Trends Immunol. 2019 Feb;40(2):88-97. doi: 10.1016/j.it.2018.12.002. Epub 2019 Jan 2. Review.

PMID:
30611647
6.

Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity.

Antonioli L, Caputi V, Fornai M, Pellegrini C, Gentile D, Giron MC, Orso G, Bernardini N, Segnani C, Ippolito C, Csóka B, Haskó G, Németh ZH, Scarpignato C, Blandizzi C, Colucci R.

Int J Obes (Lond). 2019 Feb;43(2):331-343. doi: 10.1038/s41366-018-0166-2. Epub 2018 Aug 6.

PMID:
30082748
7.

Age-dependent cardiovascular effects of sepsis in a murine model of cecal ligation and puncture: implications for the design of interventional studies.

Ungvari Z, Yabluchanskiy A, Hasko G, Pacher P.

Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1356-H1357. doi: 10.1152/ajpheart.00528.2018. Epub 2018 Aug 3. No abstract available.

8.

Quorum sensing in the immune system.

Antonioli L, Blandizzi C, Pacher P, Guilliams M, Haskó G.

Nat Rev Immunol. 2018 Sep;18(9):537-538. doi: 10.1038/s41577-018-0040-4. No abstract available.

9.

Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.

Csóka B, Németh ZH, Szabó I, Davies DL, Varga ZV, Pálóczi J, Falzoni S, Di Virgilio F, Muramatsu R, Yamashita T, Pacher P, Haskó G.

JCI Insight. 2018 Jun 7;3(11). pii: 99431. doi: 10.1172/jci.insight.99431. eCollection 2018 Jun 7.

10.

Adenosine signaling and the immune system: When a lot could be too much.

Antonioli L, Fornai M, Blandizzi C, Pacher P, Haskó G.

Immunol Lett. 2019 Jan;205:9-15. doi: 10.1016/j.imlet.2018.04.006. Epub 2018 Apr 24. Review.

PMID:
29702147
11.

Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in Mice.

Varga ZV, Erdelyi K, Paloczi J, Cinar R, Zsengeller ZK, Jourdan T, Matyas C, Nemeth BT, Guillot A, Xiang X, Mehal A, Haskó G, Stillman IE, Rosen S, Gao B, Kunos G, Pacher P.

Hepatology. 2018 Oct;68(4):1519-1533. doi: 10.1002/hep.29915.

12.

Adenosine metabolism, immunity and joint health.

Haskó G, Antonioli L, Cronstein BN.

Biochem Pharmacol. 2018 May;151:307-313. doi: 10.1016/j.bcp.2018.02.002. Epub 2018 Feb 7. Review.

13.

Adenosine receptors differentially regulate type 2 cytokine production by IL-33-activated bone marrow cells, ILC2s, and macrophages.

Csóka B, Németh ZH, Duerr CU, Fritz JH, Pacher P, Haskó G.

FASEB J. 2018 Feb;32(2):829-837. doi: 10.1096/fj.201700770R. Epub 2018 Jan 4.

14.

Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.

Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Haskó G, Mechoulam R, Gao B, Pacher P.

Sci Rep. 2017 Sep 21;7(1):12064. doi: 10.1038/s41598-017-10924-8.

15.

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Pacher P, Steffens S, Haskó G, Schindler TH, Kunos G.

Nat Rev Cardiol. 2018 Mar;15(3):151-166. doi: 10.1038/nrcardio.2017.130. Epub 2017 Sep 14. Review.

PMID:
28905873
16.

Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors.

Antonioli L, Pellegrini C, Fornai M, Tirotta E, Gentile D, Benvenuti L, Giron MC, Caputi V, Marsilio I, Orso G, Bernardini N, Segnani C, Ippolito C, Csóka B, Németh ZH, Haskó G, Scarpignato C, Blandizzi C, Colucci R.

Purinergic Signal. 2017 Dec;13(4):497-510. doi: 10.1007/s11302-017-9577-0. Epub 2017 Aug 14.

17.

A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity.

Csóka B, Törő G, Vindeirinho J, Varga ZV, Koscsó B, Németh ZH, Kókai E, Antonioli L, Suleiman M, Marchetti P, Cseri K, Deák Á, Virág L, Pacher P, Bai P, Haskó G.

FASEB J. 2017 Nov;31(11):4985-4997. doi: 10.1096/fj.201700398R. Epub 2017 Aug 1.

18.

Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies.

Antonioli L, Novitskiy SV, Sachsenmeier KF, Fornai M, Blandizzi C, Haskó G.

Drug Discov Today. 2017 Nov;22(11):1686-1696. doi: 10.1016/j.drudis.2017.06.005. Epub 2017 Jul 1. Review.

PMID:
28676406
19.

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Paloczi J, Varga ZV, Hasko G, Pacher P.

Antioxid Redox Signal. 2018 Jul 1;29(1):75-108. doi: 10.1089/ars.2017.7144. Epub 2017 Jul 18. Review.

20.

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C.

Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Review.

21.

β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.

Varga ZV, Matyas C, Erdelyi K, Cinar R, Nieri D, Chicca A, Nemeth BT, Paloczi J, Lajtos T, Corey L, Hasko G, Gao B, Kunos G, Gertsch J, Pacher P.

Br J Pharmacol. 2018 Jan;175(2):320-334. doi: 10.1111/bph.13722. Epub 2017 Feb 22.

22.

PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.

Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P.

J Hepatol. 2017 Mar;66(3):589-600. doi: 10.1016/j.jhep.2016.10.023. Epub 2016 Oct 29.

PMID:
27984176
23.

Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment.

Antonioli L, Blandizzi C, Malavasi F, Ferrari D, Haskó G.

Oncoimmunology. 2016 Jul 29;5(9):e1216292. eCollection 2016.

24.

Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.

Pellegrini C, Fornai M, Colucci R, Tirotta E, Blandini F, Levandis G, Cerri S, Segnani C, Ippolito C, Bernardini N, Cseri K, Blandizzi C, Haskó G, Antonioli L.

J Neuroinflammation. 2016 Jun 13;13(1):146. doi: 10.1186/s12974-016-0608-5.

25.

Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction, and steatosis.

Matyas C, Varga ZV, Mukhopadhyay P, Paloczi J, Lajtos T, Erdelyi K, Nemeth BT, Nan M, Hasko G, Gao B, Pacher P.

Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1658-70. doi: 10.1152/ajpheart.00214.2016. Epub 2016 Apr 22.

26.

Anti-CD73 in cancer immunotherapy: awakening new opportunities.

Antonioli L, Yegutkin GG, Pacher P, Blandizzi C, Haskó G.

Trends Cancer. 2016 Feb 1;2(2):95-109.

27.

New Piece in the Jigsaw Puzzle: Adipose Tissue-Derived Stem Cells From Obese Subjects Drive Th17 Polarization.

Csóka B, Pacher P, Bai P, Haskó G.

Diabetes. 2015 Jul;64(7):2341-3. doi: 10.2337/db15-0437. No abstract available.

28.

Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing.

Csóka B, Németh ZH, Törő G, Idzko M, Zech A, Koscsó B, Spolarics Z, Antonioli L, Cseri K, Erdélyi K, Pacher P, Haskó G.

FASEB J. 2015 Sep;29(9):3626-37. doi: 10.1096/fj.15-272450. Epub 2015 Jun 9.

29.

Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Antonioli L, Blandizzi C, Csóka B, Pacher P, Haskó G.

Nat Rev Endocrinol. 2015 Apr;11(4):228-41. doi: 10.1038/nrendo.2015.10. Epub 2015 Feb 17. Review.

PMID:
25687993
30.

Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

Hao E, Mukhopadhyay P, Cao Z, Erdélyi K, Holovac E, Liaudet L, Lee WS, Haskó G, Mechoulam R, Pacher P.

Mol Med. 2015 Jan 6;21:38-45. doi: 10.2119/molmed.2014.00261.

31.

CD39 improves survival in microbial sepsis by attenuating systemic inflammation.

Csóka B, Németh ZH, Törő G, Koscsó B, Kókai E, Robson SC, Enjyoji K, Rolandelli RH, Erdélyi K, Pacher P, Haskó G.

FASEB J. 2015 Jan;29(1):25-36. doi: 10.1096/fj.14-253567. Epub 2014 Oct 15.

32.

Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinandy P, Pacher P.

Biochim Biophys Acta. 2015 Feb;1852(2):232-42. doi: 10.1016/j.bbadis.2014.06.030. Epub 2014 Jul 2. Review.

33.

Adenosine pathway and cancer: where do we go from here?

Antonioli L, Haskó G, Fornai M, Colucci R, Blandizzi C.

Expert Opin Ther Targets. 2014 Sep;18(9):973-7. doi: 10.1517/14728222.2014.925883. Epub 2014 Jun 24.

PMID:
24958495
34.

A2B adenosine receptor induces protective antihelminth type 2 immune responses.

Patel N, Wu W, Mishra PK, Chen F, Millman A, Csóka B, Koscsó B, Eltzschig HK, Haskó G, Gause WC.

Cell Host Microbe. 2014 Mar 12;15(3):339-50. doi: 10.1016/j.chom.2014.02.001.

35.

Adenosine and inflammation: what's new on the horizon?

Antonioli L, Csóka B, Fornai M, Colucci R, Kókai E, Blandizzi C, Haskó G.

Drug Discov Today. 2014 Aug;19(8):1051-68. doi: 10.1016/j.drudis.2014.02.010. Epub 2014 Mar 6. Review.

PMID:
24607729
36.

Immunity, inflammation and cancer: a leading role for adenosine.

Antonioli L, Blandizzi C, Pacher P, Haskó G.

Nat Rev Cancer. 2013 Dec;13(12):842-57. doi: 10.1038/nrc3613. Epub 2013 Nov 14. Review.

PMID:
24226193
37.

A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation.

Csóka B, Koscsó B, Töro G, Kókai E, Virág L, Németh ZH, Pacher P, Bai P, Haskó G.

Diabetes. 2014 Mar;63(3):850-66. doi: 10.2337/db13-0573. Epub 2013 Nov 5.

38.

Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.

Mukhopadhyay P, Rajesh M, Cao Z, Horváth B, Park O, Wang H, Erdelyi K, Holovac E, Wang Y, Liaudet L, Hamdaoui N, Lafdil F, Haskó G, Szabo C, Boulares AH, Gao B, Pacher P.

Hepatology. 2014 May;59(5):1998-2009. doi: 10.1002/hep.26763. Epub 2014 Apr 1.

39.

Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages.

Koscsó B, Csóka B, Kókai E, Németh ZH, Pacher P, Virág L, Leibovich SJ, Haskó G.

J Leukoc Biol. 2013 Dec;94(6):1309-15. doi: 10.1189/jlb.0113043. Epub 2013 Aug 6.

40.

CD39 and CD73 in immunity and inflammation.

Antonioli L, Pacher P, Vizi ES, Haskó G.

Trends Mol Med. 2013 Jun;19(6):355-67. doi: 10.1016/j.molmed.2013.03.005. Epub 2013 Apr 17. Review.

41.

Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury.

Koscsó B, Trepakov A, Csóka B, Németh ZH, Pacher P, Eltzschig HK, Haskó G.

Purinergic Signal. 2013 Sep;9(3):427-32. doi: 10.1007/s11302-013-9362-7. Epub 2013 Apr 13.

42.

Regulation of inflammation by adenosine.

Haskó G, Cronstein B.

Front Immunol. 2013 Apr 8;4:85. doi: 10.3389/fimmu.2013.00085. eCollection 2013.

43.

Cytoprotective dibenzoylmethane derivatives protect cells from oxidative stress-induced necrotic cell death.

Hegedűs C, Lakatos P, Kiss-Szikszai A, Patonay T, Gergely S, Gregus A, Bai P, Haskó G, Szabó É, Virág L.

Pharmacol Res. 2013 Jun;72:25-34. doi: 10.1016/j.phrs.2013.03.002. Epub 2013 Mar 21.

PMID:
23523665
44.

The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling.

Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S, Leibovich SJ.

Inflammation. 2013 Aug;36(4):921-31. doi: 10.1007/s10753-013-9621-3.

45.

Induction of murine adenosine A(2A) receptor expression by LPS: analysis of the 5' upstream promoter.

Elson G, Eisenberg M, Garg C, Outram S, Ferrante CJ, Hasko G, Leibovich SJ.

Genes Immun. 2013 Apr;14(3):147-53. doi: 10.1038/gene.2012.60. Epub 2013 Jan 17.

PMID:
23328845
46.

Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.

Cao Z, Mulvihill MM, Mukhopadhyay P, Xu H, Erdélyi K, Hao E, Holovac E, Haskó G, Cravatt BF, Nomura DK, Pacher P.

Gastroenterology. 2013 Apr;144(4):808-817.e15. doi: 10.1053/j.gastro.2012.12.028. Epub 2013 Jan 4.

47.

3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism.

Lakatos P, Szabó É, Hegedűs C, Haskó G, Gergely P, Bai P, Virág L.

Biochim Biophys Acta. 2013 Mar;1833(3):743-51. doi: 10.1016/j.bbamcr.2012.12.003. Epub 2012 Dec 12.

48.

Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation.

Wei W, Du C, Lv J, Zhao G, Li Z, Wu Z, Haskó G, Xie X.

J Immunol. 2013 Jan 1;190(1):138-46. doi: 10.4049/jimmunol.1103721. Epub 2012 Dec 5.

49.

Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death.

Kovács K, Erdélyi K, Hegedűs C, Lakatos P, Regdon Z, Bai P, Haskó G, Szabó E, Virág L.

Free Radic Biol Med. 2012 Nov 1;53(9):1680-8. doi: 10.1016/j.freeradbiomed.2012.08.579. Epub 2012 Aug 27.

PMID:
22964577
50.

Regulation of macrophage function by adenosine.

Haskó G, Pacher P.

Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):865-9. doi: 10.1161/ATVBAHA.111.226852. Review.

Supplemental Content

Support Center